These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 823795)

  • 1. Tuberculin shock in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):273-79. PubMed ID: 823795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired resistance against Listeria monocytogenes in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):379-85. PubMed ID: 826109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of purified tuberculin determined by the shock method on hamsters.
    Jespersen A
    Acta Pathol Microbiol Scand C; 1976 Feb; 84(1):1-4. PubMed ID: 773097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCG.
    Portelance V; Brasseur R; Boulanger RP
    Can J Microbiol; 1975 Oct; 21(10):1492-9. PubMed ID: 1104114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
    Lagrange PH
    Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of TAS-1D3, a tuberculin-active substance from BCG, in regard to delayed hypersensitivity.
    Yano O; Toizumi S; Sudo T
    Microbiol Immunol; 1984; 28(10):1149-57. PubMed ID: 6441106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to BCG-Moreau (Rio de Janeiro) strain. Spectrum of delayed hypersensitivity in genetically defined mice.
    Mortatti RC; Maia LC
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):491-7. PubMed ID: 2627501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of old tuberculin and purified protein derivative in Macaca mulatta.
    Smith AW; Wolochow H
    Lab Anim Sci; 1973 Jun; 23(3):373-6. PubMed ID: 4351474
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice.
    Collins FM; Mackaness GB
    Cell Immunol; 1970 Sep; 1(3):253-65. PubMed ID: 5002229
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.
    Collins FM
    Infect Immun; 1971 Dec; 4(6):688-96. PubMed ID: 5005311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cell migration as a model for delayed hypersensitivity.
    GEORGE M; VAUGHAN JH
    Proc Soc Exp Biol Med; 1962 Nov; 111():514-21. PubMed ID: 13947220
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative testing of the potency of different PPD preparations.
    Zsidai J; Joó I
    Dev Biol Stand; 1986; 58 ( Pt B)():599-605. PubMed ID: 3111905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro boosting effects of tuberculin skin tests in guinea-pigs immunized with living BCG or with killed Mycobacterium tuberculosis.
    Hasløv K; Møller S; Bentzon MW
    Acta Pathol Microbiol Immunol Scand C; 1984 Apr; 92(2):101-6. PubMed ID: 6375252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCG.
    Lagranderie M; Balazuc AM; Abolhassani M; Chavarot P; Nahori MA; Thouron F; Milon G; Marchal G
    Scand J Immunol; 2002 Mar; 55(3):293-303. PubMed ID: 11940236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUBERCULIN PRODUCTION. 4. SPECIFICITY OF TUBERCULIN OF MYCOBACTERIUM TUBERCULOSIS AND M. BOVIS (BCG STRAIN).
    KIM HK; MAGNUSSON M; BENTZON MW
    Acta Pathol Microbiol Scand; 1964; 60():241-52. PubMed ID: 14121982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.